Provectus Pharmaceuticals, Inc. (NASDAQOTH:PVCT)

CAPS Rating: 1 out of 5

A development-stage biopharmaceutical company that is focusing on developing minimally invasive products for the treatment of psoriasis and other topical diseases, and certain forms of cancer.

PVCT News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

26 Outperform
23 Underperform
 

All-Star Players

2 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top PVCT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JungleDoctor (< 20)
Submitted January 18, 2012

I've followed the research on their products for a couple of years and PV-10 looks promising for melanoma. Chris Sawyer, MD

NeroSagetrade (91.53)
Submitted October 03, 2007

Wow....seriously wow.... $288 in full year revenues...thats not in billions, millions, tens or even thousands. Thats $288 DOLLARS in full year revenues. They have ONE...yes, ONE drug in mid-phase trials, are producing 4-5 million in yearly losses and… More

PVCT VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about PVCT.

Recs

0
Member Avatar joelkatz (< 20) Submitted: 2/3/2014 7:58:49 PM : Outperform Start Price: $1.97 PVCT Score: -143.82

FDA approval comingsoon

Recs

0
Member Avatar ICanFool (< 20) Submitted: 1/31/2014 12:02:39 PM : Outperform Start Price: $1.35 PVCT Score: -139.76

Red Bengal (=PV-10) is a miracle drug unnoticed... It has been used safely by opthalmologists as a dye in the eye. Cancer cells selectively absorb this dye. At 10% Concentration it destroys even HIV ...mmmm interesting drug but needs to proven with several combination permutation per FDA request.. Orphan drug at this point. Has high potential. more links at http://provectuspharmaceuticalsinc.blogspot.com/2014/01/pv-10s-pharmaceutical-alpha.html

Recs

0
Member Avatar Jberk (< 20) Submitted: 1/22/2014 6:58:06 PM : Outperform Start Price: $5.60 PVCT Score: -138.45

PV-10 drug cures melanoma,in the pipeline... Soon to get FDA approval! Stock at $5.22.... Analyst values share price at $62.04!!

http://smallcapstreet.com/pvtc/

Leaderboard

Find the members with the highest scoring picks in PVCT.

Score Leader

Stockjockey101

Stockjockey101 (< 20) Score: +339.65

The Score Leader is the player with the highest score across all their picks in PVCT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stockjock11 < 20 3/29/2010 Underperform NS $1.75 -97.71% +117.78% +215.49 0 Comment
SneakyPete21 < 20 11/24/2010 Underperform 5Y $0.95 -95.79% +114.07% +209.86 0 Comment
DorminABC 99.88 3/16/2011 Underperform NS $0.92 -95.63% +101.76% +197.39 0 Comment
KnowNoFear 23.45 5/15/2012 Underperform 5Y $0.85 -95.29% +91.31% +186.60 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. unanimousonestar 96.30 11/26/2007 Underperform NS $2.22 -98.20% +85.10% +183.30 0 Comment
treegood1 < 20 9/17/2007 Underperform NS $2.58 -98.45% +81.27% +179.72 0 Comment
jaspayd 68.11 9/18/2007 Underperform NS $2.24 -98.21% +80.05% +178.26 0 Comment
Surge07 94.17 9/26/2007 Underperform 5Y $2.44 -98.36% +75.60% +173.96 0 Comment
Lance912 26.89 9/27/2007 Underperform 5Y $2.43 -98.35% +75.08% +173.43 0 Comment
NeroSagetrade 91.53 10/3/2007 Underperform 3Y $2.35 -98.30% +73.81% +172.11 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PVCT.

Featured Broker Partners